Press Release

Urinary Catheters Market to Grow with a CAGR of 5.28% through 2030

Growing Prevalence of Urological Disorders and Chronic Diseases and Rapidly Aging Global Population are expected to drive the Global Urinary Catheters Market growth in the forecast period, 2026-2030

 

According to TechSci Research report, “Urinary Catheters Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Urinary Catheters Market stood at USD 5.78 Billion in 2024 and is anticipated to grow with a CAGR of 5.28% in the forecast period.

Ongoing innovation in catheter design and materials is accelerating adoption by delivering measurable improvements in clinical outcomes, user experience, and safety standards. Hydrophilic-coated catheters reduce insertion friction, lowering the risk of urethral trauma and improving comfort during repeated use particularly critical for chronic patients practicing intermittent self-catheterization. Antimicrobial coatings help mitigate catheter-associated urinary tract infections (CAUTIs), a primary concern for healthcare providers and a major cost driver for hospitals.

Automatic balloon-deflation mechanisms, such as those featured in advanced indwelling catheter models, are designed to prevent traumatic injuries caused by accidental removal, enhancing patient safety in both acute and long-term care settings. Additionally, next-generation platforms like Bright Uro’s Glean™ wireless urodynamics system are expanding the application scope of catheter-related diagnostics, allowing for remote, catheter-free assessment of bladder function. These advancements not only meet regulatory and clinical expectations but also contribute to higher patient satisfaction, repeat usage, and stronger brand equity. Innovative, high-performance products improve clinical acceptance, support regulatory compliance, and enhance patient loyalty driving premium pricing and long-term market positioning.

Global healthcare systems are increasingly embracing home-based care models in an effort to contain costs and improve quality of life for chronic patients. Self-catheterization, especially using intermittent catheters, is at the forefront of this trend. Patients with chronic urological conditions such as neurogenic bladder, spinal cord injuries, or long-term urinary retention are now empowered to manage their condition independently, reducing dependency on hospital-based care. Pre-lubricated, compact, and discreet catheter designs are being developed specifically for ease of use in non-clinical settings. The trend is particularly strong in developed regions such as North America, Western Europe, and Japan, where infrastructure supports patient training and insurance systems offer favorable reimbursement for home-use products. This growing preference for convenience, hygiene, and autonomy is shifting market dynamics toward retail-oriented demand, with recurring purchases becoming more common through direct-to-consumer and pharmacy channels. The rise of home healthcare expands the total addressable market, diversifies revenue streams beyond institutional sales, and increases repeat consumption through consumer-driven purchasing behavior.

Robust healthcare policies and insurance coverage in major markets are playing a pivotal role in mainstreaming urinary catheter usage as a standard therapeutic intervention. In the United States, products are covered under Medicare Part B and private insurance plans, supporting both short- and long-term catheterization. National guidelines from authoritative bodies such as the American Urological Association (AUA) recognize catheterization as a first-line intervention for managing a wide range of bladder dysfunctions. In regions such as Europe and Japan, reimbursement frameworks incentivize early and continuous catheter-based treatment, while public health campaigns improve diagnosis rates and reduce stigma associated with catheter use. This structured support not only enhances product affordability and accessibility but also accelerates provider confidence and prescription rates thereby driving predictable market growth. A supportive reimbursement and policy environment reduces financial barriers for patients, increases market penetration for suppliers, and solidifies catheterization as a standard of care across diverse healthcare systems.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Urinary Catheters Market

 

The Global Urinary Catheters Market is segmented into product, application, type, end user, regional distribution, and company.

Based on its type, the Coated Catheters segment has emerged as the predominant market leader, Coated catheters are engineered with advanced surface technologies, including hydrophilic coatings and antimicrobial agents (such as silver alloy or nitrofurazone), which significantly reduce the risk of catheter-associated urinary tract infections (CAUTIs) a leading cause of hospital-acquired infections and increased healthcare costs. Hospitals and long-term care facilities are increasingly prioritizing coated options to comply with infection control guidelines and reduce treatment complications. The improved safety profile of coated catheters makes them the preferred choice for long-term catheterization and high-risk patients.

Hydrophilic-coated catheters provide low-friction insertion and removal, which minimizes urethral trauma and discomfort. This feature is particularly important for individuals practicing intermittent self-catheterization, including patients with spinal cord injuries, multiple sclerosis, or chronic urinary retention. The enhanced ease of use not only improves patient adherence but also supports the shift toward home-based urological care, especially in developed markets.

Based on region, Asia Pacific region is poised to experience the fastest growth in the Global Urinary Catheters Market, driven by Lifestyle changes, increasing obesity, sedentary behavior, and longer life expectancy are fueling the incidence of chronic illnesses such as diabetes, neurological disorders, and renal complications many of which lead to bladder dysfunction or require catheterization. India and China collectively account for over millions of people with diabetes a leading cause of neurogenic bladder. The growing incidence of prostate enlargement and related conditions is increasing the need for both intermittent and indwelling catheter use.

Many APAC governments are heavily investing in public healthcare systems, rural health outreach, and hospital capacity building. This includes programs promoting access to urology services, procurement of medical devices, and training for healthcare providers. China’s "Healthy China 2030" initiative supports increased access to chronic disease management tools. In India, the expansion of national health insurance (Ayushman Bharat) is increasing affordability of urological treatments and devices. These developments are widening the availability and accessibility of urinary catheters in both urban and underserved areas.

 

Major companies operating in Global Urinary Catheters Market are:

  • Hollister Incorporated
  • Medtronic PLC
  • Boston Scientific Corporation
  • BD
  • Cook Medical
  • Convatec Inc
  • Teleflex Incorporated
  • Coloplast Corp
  • B. Braun SE
  • Medline Industries, LP

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The Global Urinary Catheters Market is positioned for sustained expansion, underpinned by aging demographics, rising prevalence of urological and chronic health conditions, increasing demand for home-based care, and continuous product innovation. As healthcare systems prioritize infection control, patient comfort, and cost-effective chronic disease management, urinary catheters are becoming a cornerstone in both acute and long-term care settings. Companies that focus on advanced materials, user-centric design, regulatory compliance, and regional market adaptability particularly in high-growth regions like Asia Pacific will be best positioned to capture market share and create long-term value. Strategic investment in R&D, patient education, and diversified distribution will be essential to stay competitive in this evolving, demand-driven global market.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

Urinary Catheters Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Intermittent Catheters, Foley/ Indwelling Catheters, External Catheters), By Application (Benign Prostate Hyperplasia & Prostate Surgeries, Urinary Incontinence, Spinal Cord Injury, Others), By Type (Coated Catheters, Uncoated Catheters), By End User (Hospital, Clinics, Long-Term Care Facilities, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global Urinary Catheters Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Urinary Catheters Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Relevant News